This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

W. Lee Fanning, MD; Dieter W. Gump, MD

Arch Intern Med. 1976;136(7):761-762.

Abstract
Minocycline hydrochloride is a tetracycline derivative that has been advocated as the drug of choice in the treatment of meningococcal carriers. Recently, we studied a group of 30 patients who experienced a large number of sideeffects after receiving minocycline for treatment of meningococcal meningitis. Twenty-seven of 30 (90%) suffered from dizziness, vertigo, ataxia, weakness, nausea, and vomiting. These symptoms appeared within the first 72 hours of taking minocycline, and disappeared within 48 hours of stopping the medication.

(Arch Intern Med 136:761-762, 1976)

Author Affiliations
From the Department of Medicine, University of Vermont College of Medicine, Burlington.

Footnotes
Received for publication June 13, 1975; accepted Oct 11.

Reprint requests to Infectious Disease Unit, Department of Medicine, Given Building C315, University of Vermont College of Medicine, Burlington, VT 05401 (Dr Fanning).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Minocycline Treatment of Pulmonary Nocardiosis
Petersen et al.
JAMA 1983;250:930-932.
ABSTRACT